Abstract
Dunning R3327 AT-1 rat prostate tumor cells were transfected with a double-fusion suicide gene (CDglyTK) that coded for the cytosine deaminase from E. coli and the thymidine kinase (TK) from HSV-1. The resulting cell line AT-1/CDglyTK was incubated with 10 and 20 μg/ml 5-FC or 0.25 μg/ml GCV, or both 5-FC and GCV 96 hours before harvest. The MTS assay detected cell viabilities of 50±5 and 25±5% after 5-FC treatment, and 50±5% after GCV treatment. The dye exclusion and the colony-forming assay confirmed the data of the MTS assay with GCV (47±5 and 32±5%), but presented different results for the 5-FC incubation. We detected 100±1 and 85±5% viable cells after 10 μg/ml 5-FC, and 97±1 and 85±5% after 20 μg/ml 5-FC treatment, respectively. S-phase arrest in both suicide gene systems was noticeable and a significant increase in cell granularity was observed after incubation with GCV or GCV & 5-FC. This study demonstrates that 5-FC and the metabolized 5-FU act not only as genotoxic reagents, but also as RNA-directed agent, because of the recovery of the cells. On the other hand, a significant S-phase block could be observed after 24 hours incubation with GCV. This short time is enough to incorporate the genotoxic GCV metabolites in the nascent DNA to impair the cell cycle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hamzeh FM, Lietman PS . Intranuclear accumulation of subgenomic noninfectious human cytomegalovirus DNA in infected cells in the presence of ganciclovir. Antimicrob Agents Chemother. 1991;35:1818–1823.
Haynes P, Lambert TR, Mitchell ID . Comparative in-vivo genotoxicity of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay. Mutat Res. 1996;369:65–74.
Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature. 1957;179:663–666.
Willmore E, Durkacz BW . Cytotoxic mechanisms of 5-fluoropyrimidines. Relationships with poly(ADP-ribose) polymerase activity, DNA strand breakage and incorporation into nucleic acids. Biochem Pharmacol. 1993;46:205–211.
Weckbecker G . Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators. Pharmacol Ther. 1991;50:367–424.
Daher GC, Harris BE, Diasio RB . Metabolism of pyrimidine analogues and their nucleosides. Pharmacol Ther. 1990;48:189–222.
Inaba M, Mitsuhashi J . Flow cytometric analysis of cell-killing actions of 5-fluorouracil in human colorectal cancer cells. Oncol Res. 1994;6:303–309.
Barltrop JA, Owen TC, Cory AH, Cory JG . 5-(3-Carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg Med Chem Lett. 1991;1:611.
Freshney RI . Culture of Animal Cells — A Manual of Basic Technique 4th edn. Wiley-Liss; New York, U.S.A., 2000.
Ehmann GL, McLean TI, Bachenheimer SL . Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells. Virology. 2000;267:335–349.
Grem JL . 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development. Investig New Drugs. 2000;18:299–313.
Beltinger C, Fulda S, Kammertoens T, Uckert W, Debatin KM . Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. Cancer Res. 2000;60:3212–3217.
Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W, Debatin KM . Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci USA. 1999;96:8699–8704.
Wang ZH, Samuels S, Gama-Sosa MA, Kolodny EH . 5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with interferon. J Neurooncol. 1998;36:219–229.
Rubsam LZ, Davidson BL, Shewach DS . Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing. Cancer Res. 1998;58:3873–3882.
Isaacs JT, Isaacs WB, Feitz WF, Scheres J . Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate. 1986;9:261–281.
Rogulski KR, Kim JH, Kim SH, Freytag SO . Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther. 1997;8:73–85.
Haack K, Moebius U, Knebel-Doeberitz MV, Herfarth C, Schackert HK, Gebert JF . Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies. Hum Gene Ther. 1997;8:1395–1401.
Otto FJ . High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. Methods Cell Biol. 1994;41:211–217.
Foglieni C, Meoni C, Davalli AM . Fluorescent dyes for cell viability: an application on prefixed conditions. Histochem Cell Biol. 2001;115:223–229.
Cory AH, Owen TC, Barltrop JA, Cory JG . Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991;3:207–212.
Wu XP, Dolnick BJ . 5-Fluorouracil alters dihydrofolate reductase pre-mRNA splicing as determined by quantitative polymerase chain reaction. Mol Pharmacol. 1993;44:22–29.
Corban-Wilhelm H, Hull WE, Becker G, Bauder-Wust U, Greulich D, Debus J . Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with (19)F-NMR spectroscopy. Gene Therapy. 2002;9:1564–1575.
Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH . Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta. 1992;1133:275–285.
Huschtscha LI, Jeitner TM, Andersson CE, Bartier WA, Tattersall MH . Identification of apoptotic and necrotic human leukemic cells by flow cytometry. Exp Cell Res. 1994;212:161–165.
Yoshimura I, Suzuki S, Tadakuma T, Hayakawa M . Suicide gene therapy on LNCaP human prostate cancer cells. Int J Urol. 2001;8:S5–S8.
Calabresi P, Chabner BA . Chemotherapy of neoplastic diseases. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman & Gilman's “The Pharmacological Basis of Therapeutics”. New York: McGraw-Hill; 1995: 1225–1287.
Thust R, Schacke M, Wutzler P . Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues. Antiviral Res. 1996;31:105–113.
Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA . Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst. 1998;90:370–380.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corban-Wilhelm, H., Ehemann, V., Becker, G. et al. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther 11, 208–214 (2004). https://doi.org/10.1038/sj.cgt.7700667
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700667
Keywords
This article is cited by
-
5-Fluorocytosine–Sugar Conjugates for Glucose Transporter-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism
Transactions of Tianjin University (2019)
-
Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging
Cancer & Metabolism (2013)
-
Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging
Gene Therapy (2013)
-
Emerging Implications of Nonmammalian Cytosine Deaminases on Cancer Therapeutics
Applied Biochemistry and Biotechnology (2012)
-
Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On
Cancer Gene Therapy (2006)